SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celgene-CELG -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (275)2/11/1999 9:11:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 804
 
Tonight DJ has a story on ENMD's option on finding a third party to develop angiostatin. Details linked to Anti-Angiogenesis table of New Therapeutics section of biocognizance.com



To: Miljenko Zuanic who wrote (275)2/12/1999 12:09:00 AM
From: John Bloxom  Read Replies (1) | Respond to of 804
 
Miljenko:

<<PS: So, are you now back to ENMD?>>

Not yet.

I like it at $10 or so on current data.

Love that CELG, however. Have a truckload at average cost of $9.00 or so.

Regards,

John